Previous 10 | Next 10 |
2023-05-02 18:30:33 ET The stock of medical aesthetics tech company InMode (NASDAQ: INMD) wasn't looking very pretty on Tuesday. The company published its latest set of quarterly figures, and some investors found them sorely wanting. In consequence the share price took a 10% hit on ...
2023-05-02 12:30:33 ET Image source: The Motley Fool. InMode (NASDAQ: INMD) Q1 2023 Earnings Call May 02, 2023 , 8:30 a.m. ET Operator Continue reading For further details see: InMode (INMD) Q1 2023 Earnings Call Transcript
2023-05-02 11:17:09 ET Summary InMode is a pioneer, first mover and leader in the field of minimally-invasive treatment and it generates mouth-watering returns. InMode is set to exceed investors' expectations embedded in today's share price even if a recession hits. Demand will li...
2023-05-02 11:16:02 ET InMode Ltd. (INMD) Q1 2023 Earnings Conference Call May 2, 2023 8:30 AM ET Company Participants Miri Segal - Investor Relations, MS-IR LLC Moshe Mizrahy - Chairman and CEO Shakil Lakhani - President, North America Yair Malca - Chief Fin...
2023-05-02 07:03:28 ET InMode press release ( NASDAQ: INMD ): Q1 Non-GAAP EPS of $0.52. Revenue of $106.1M (+23.5% Y/Y). Shares -4.2% PM. 2023 Financial Outlook: Revenue between $525 million and $530 million (vs. consensus $530.71B); Non-GAAP gross ...
2023-04-12 08:56:34 ET Wednesday's U.S. equity trading will center around the government's latest inflation statistics, released before the opening bell. The futures spiked following the release of a softer CPI reading for March, with the headline figure rising 5% from last year . Here ...
2023-04-12 07:22:48 ET InMode ( NASDAQ: INMD ) announced on Wednesday its preliminary Q1 results. The company expects Q1 revenue in the range of $105.7M to $105.9M vs. consensus of $100.25M. Non-GAAP earnings per diluted share are estimated to come in th...
InMode Expects First Quarter 2023 Revenue Between $105.7-$105.9M, Non-GAAP Earnings per Diluted Share Between $0.50-$0.51 PR Newswire Conference call to be held on Tuesday, May 2, 2023, at 8:30 a.m. Eastern Time YOKNEAM, Israel , April 12, 2023 /PRN...
2023-03-30 01:09:06 ET Summary InMode is a small-cap medical device company that invented a new way to do plastic surgery in a non-invasive way, via radio waves. The company is dominating its niche market, and the stock is up almost 400% since the IPO. The potential upside of ...
2023-03-29 08:17:00 ET Despite being one of the world's largest, most steadily growing businesses, Amazon 's (NASDAQ: AMZN) stock fell by around 40% in the last 12 months, leaving investors looking for alternatives to buy for growth. Nonetheless, Wall Street analysts predict that Am...
News, Short Squeeze, Breakout and More Instantly...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient Asserts the Current Valuation Offers an Unprecedented Oppo...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...